p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.
about
Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulator.FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated SchwannomasThe Rac GTPase effector p21-activated kinase is essential for hematopoietic stem/progenitor cell migration and engraftment.Comprehensive pharmacological profiling of neurofibromatosis cell lines.Group I Paks as therapeutic targets in NF2-deficient meningioma.Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.Vulvar malignancy in neurofibromatosis syndromeCrizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1.Inactivation of Merlin in malignant mesothelioma cells and the Hippo signaling cascade dysregulation.p21-activated kinase 1: PAK'ed with potential.PAK signaling in cancer.Targeting group I p21-activated kinases to control malignant peripheral nerve sheath tumor growth and metastasis.P21-activated kinase 1 (PAK1) as a therapeutic target in BRAF wild-type melanoma.Inhibiting p21-Activated Kinase Induces Cell Death in Vestibular Schwannoma and Meningioma via Mitotic Catastrophe.Group I Paks are essential for epithelial- mesenchymal transition in an Apc-driven model of colorectal cancer
P2860
Q26825296-433E338B-37DE-459C-807F-849ECBBB20EFQ27679769-B4A14AFE-A2B2-47FB-B427-C5BCCC994C0BQ30538230-EA7653B8-0C43-4D9A-BE9B-DB877CC5092AQ33622690-54B7DFA1-8F93-4A30-A087-2C1202E639ADQ35273319-02ACF0CD-5E72-4BB2-B1FE-FF61FB807252Q36247613-094909C5-A07C-41CE-9151-C87A06362EFCQ37220286-FDF7F8AF-0886-4D4D-8C3A-1DBC3B014492Q37688093-A2944F44-D2E1-4A1B-A506-B85905DC55BEQ37880216-B50EF5D3-5CAE-46E4-863E-E8DE7765B3B4Q37886485-CA77C1D1-37DB-4BCD-8594-7AC7B61CDA32Q38060732-19F9B459-875F-4CD4-93DC-4F92BF56618BQ38769437-01A5BBFA-2CDC-4960-9EE4-7EE3270A203FQ39174795-CB7501C3-084D-4812-A492-ECC30DD5A4AEQ40534803-D001E571-A0D7-45D9-939F-9EF021889FE2Q57980063-2F537E6F-D08C-4221-8426-14FFFFC7FCA5
P2860
p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
p21-Activated kinases are requ ...... l of neurofibromatosis type 2.
@ast
p21-Activated kinases are requ ...... l of neurofibromatosis type 2.
@en
type
label
p21-Activated kinases are requ ...... l of neurofibromatosis type 2.
@ast
p21-Activated kinases are requ ...... l of neurofibromatosis type 2.
@en
prefLabel
p21-Activated kinases are requ ...... l of neurofibromatosis type 2.
@ast
p21-Activated kinases are requ ...... l of neurofibromatosis type 2.
@en
P2093
P2860
P1433
P1476
p21-Activated kinases are requ ...... l of neurofibromatosis type 2.
@en
P2093
Dina Stepanova
Hoi Yee Chow
Jennifer Koch
P2860
P304
P356
10.1371/JOURNAL.PONE.0013791
P407
P577
2010-11-02T00:00:00Z